Compare HYFM & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYFM | MBAI |
|---|---|---|
| Founded | 1977 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 10.6M |
| IPO Year | 2020 | N/A |
| Metric | HYFM | MBAI |
|---|---|---|
| Price | $1.37 | $1.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.0K | ★ 7.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,288,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $51.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.35 | $1.31 |
| 52 Week High | $5.80 | $3.92 |
| Indicator | HYFM | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.54 | 49.76 |
| Support Level | $1.40 | $1.71 |
| Resistance Level | $1.48 | $1.88 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 66.64 |
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.